Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma

NCT00053092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]